JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouilleret, V.
Right arrow Articles by Ribeiro, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouilleret, V.
Right arrow Articles by Ribeiro, M.-J.
Journal of Nuclear Medicine Vol. 46 No. 3 540-547
© 2005 by Society of Nuclear Medicine


Basic Science Investigations

Involvement of the Basal Ganglia in Refractory Epilepsy: An 18F-Fluoro-L-DOPA PET Study Using 2 Methods of Analysis

Viviane Bouilleret, MD, PhD1,2, Franck Semah, MD1, Arnaud Biraben, MD3, Delphine Taussig, MD3, Francine Chassoux, MD1,4, André Syrota, MD, PhD1 and Maria-João Ribeiro, MD, PhD1

1 Commissariat à l’Energie Atomique, Direction des Sciences du Vivant, Département de Recherche Médicale, Service Hospitalier Frédéric Joliot, Orsay, France
2 Unité de Neurophysiologie et d’Epileptologie, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
3 Service de Neurologie, CHU Pontchaillou, Rennes, France
4 Service de Neurochirurgie, Hôpital Saint Anne, Paris, France

Studies in animal models and epileptic patients have led to the suggestion that the basal ganglia (BG) are involved in seizures. PET with 6-18F-L-3,4-fluorodihydroxyphenylalanine (18F-fluoro-L-DOPA) has recently demonstrated a reduction of striatal dopamine uptake in drug-resistant epileptic patients with ring chromosome 20 (r20) using a multiple-time graphical analysis. The aim of the present study was to evaluate the involvement of dopamine in other epileptic syndromes using a multiple-time graphical analysis and the all-brain statistical parametric mapping (SPM) analysis. Methods: Patients with drug-resistant epilepsy were divided into 3 groups: group 1, with r20 epilepsy (n = 16; mean age ± SD, 21.5 ± 5.4 y); group 2, with resistant generalized "absence-like" epilepsy (n = 10; mean age, 32.3 ± 11.4 y); and group 3, with drug-resistant temporal lobe epilepsy with hippocampal sclerosis (n = 9; mean age, 35.2 ± 10.3 y). We compared 2 strategies of analysis of the 18F-fluoro-L-DOPA uptake constant (Ki, min–1) in BG using a multiple-time graphical analysis using regions of interest (the gold-standard method) and an SPM analysis using a voxel-by-voxel statistical t test to avoid a priori hypotheses in the analysis. Each epileptic group was compared with a group of healthy volunteers (n = 10; mean age, 45.1 ± 16.5 y). Results: A decrease of the mean Ki value was observed in the striatum in all groups of patients with both types of analysis. With multiple-time graphical analysis, the reduction was evident using the averaged Ki values over both hemispheres in each BG. Unilateral decreases in each BG were detected in SPM analysis. A ratio of decrease of 18F-fluoro-L-DOPA uptake was observed in the 3 groups of patients. Only the SPM analysis showed a decrease of 18F-fluoro-L-DOPA uptake ipsilateral to the seizure side in patients with temporal lobe epilepsy. Moreover, the all-brain SPM analysis showed a decrease of 18F-fluoro-L-DOPA uptake in the substantia nigra bilaterally (P < 0.001). Conclusion: This result confirms the involvement of dopamine neurotransmission in seizure control related to the type of epileptic syndrome. The difference in epileptic types may depend in part on the seizure frequency.

Key Words: epileptic syndromes • basal ganglia • PET • 18F-fluoro-L-DOPA




This article has been cited by other articles:


Home page
NeurologyHome page
S. R. Haut and R. L. Albin
Dopamine and epilepsy: Hints of complex subcortical roles
Neurology, September 9, 2008; 71(11): 784 - 785.
[Full Text] [PDF]


Home page
NeurologyHome page
C. Ciumas, T-B R. Wahlin, A. Jucaite, P. Lindstrom, C. Halldin, and I. Savic
Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy
Neurology, September 9, 2008; 71(11): 788 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
O. Darbin and T. Wichmann
Effects of Striatal GABAA-Receptor Blockade on Striatal and Cortical Activity in Monkeys
J Neurophysiol, March 1, 2008; 99(3): 1294 - 1305.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
V. Bouilleret, F. Semah, F. Chassoux, M. Mantzaridez, A. Biraben, R. Trebossen, and M. -J. Ribeiro
Basal ganglia involvement in temporal lobe epilepsy: A functional and morphologic study
Neurology, January 15, 2008; 70(3): 177 - 184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.